Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Therapy-Related Myeloid Neoplasms with Balanced Chromosome Rearrangements Frequently Arise from Pre-Existing Clonal Haematopoiesis

Richard Dillon, MA, PhD MRCP, FRCPath, Jelena Jovanovic, PhD, Nicola Potter, PhD, Nicola Foot, MSc, Matthew J Ahearne, MD MBBS, Sandrine Jayne, PhD, Michael Dennis, MD MRCP, FRCPath, Ann E. Hunter, MBBS, FRCP, FRCPath, Martin J.S. Dyer, Paresh Vyas, Lynn Quek, FRCPath, DPhil, MBBS, Nigel H. Russell, Robert K. Hills, MA, DPhil, MSc, Ellen Solomon, PhD, David Grimwade, PhD MRCP, MRCPath

Blood (2018) 132 (Supplement 1): 2570.

https://doi.org/10.1182/blood-2018-99-114233

Published: 2018

Journal Articles

Pre-Transplant NPM1 Mutant Transcript Level Is Highly Predictive of Outcome after Allograft and Thresholds Are Dependent on FLT3 ITD Status

Richard Dillon, MA, PhD MRCP, FRCPath, Robert K. Hills, MA, DPhil, MSc, Sylvie D Freeman, MBChB, DPhil, Nicola Potter, PhD, Adam Ivey, BSc, MSc, PhD, Jelena Jovanovic, PhD, Anju Kanda, MSc, Manohursingh Runglall, MSc, Nicola Foot, MSc, Laura Upton, Asim Khwaja, MD PhD, Jamie Cavenagh, MD PhD, Ruth Spearing, MD, Alan K. Burnett, MD, Nigel H. Russell, David Grimwade, PhD MRCP, MRCPath

Blood (2018) 132 (Supplement 1): 2739.

https://doi.org/10.1182/blood-2018-99-113662

Published: 2018

Journal Articles

Long Term Follow up from the NCRI AML17 Trial of Attenuated Arsenic Trioxide and ATRA Therapy for Newly Diagnosed and Relapsed Acute Promyelocytic Leukaemia

Nigel H Russell, MD, Alan K. Burnett, MD FRCP, Robert K Hills, DPhil, Sophie Betteridge, PhD, Michael Dennis, FRCPath, Richard Dillon, MA, MRCP, FRCPath, David Grimwade, PhD FRCPath

Blood (2016) 128 (22): 897.

https://doi.org/10.1182/blood.V128.22.897.897

Published: 2016

Journal Articles

Pml Nuclear Body Disruption Cooperates in APL Pathogenesis, Impacting DNA Damage Repair Pathways

Edwige Voisset, PhD, Eva Moravcsik, Eva W Stratford, Amie Jaye, Christopher J Palgrave, Robert K Hills, DPhil, Paolo Salomoni, Scott C. Kogan, MD, Ellen Solomon, David Grimwade, PhD FRCPath

Blood (2016) 128 (22): 742.

https://doi.org/10.1182/blood.V128.22.742.742

Published: 2016

Journal Articles

Prognostic Significance and Risk Stratification in Acute Myeloid Leukaemia Patients in the Absence of Successful Cytogenetic Analysis

Lucy Chilton, PhD, Christine Harrison, PhDFRCPath FMedSci, Anthony V. Moorman, PhD, Iona Ashworth, Alan K. Burnett, MD FRCP, David Grimwade, PhD FRCPath, Robert K Hills, MA MSc DPhil

Blood (2015) 126 (23): 1379.

https://doi.org/10.1182/blood.V126.23.1379.1379

Published: 2015

Journal Articles

Significance of Blast CD33 Expression for Effect of Gemtuzumab Ozogamicin at Different Doses in Adult Acute Myeloid Leukemia: Results from the UK NCRI AML16/17 Trials

Khan Naeem, PhD, Robert K. Hills, MA, MSc, DPhil, Paul Virgo, BSc,, Stephen Couzens, Nithiya Clark, Amanda Gilkes, Angela Grech, Peter Richardson, Steven Knapper, David Grimwade, PhD FRCPath, Nigel H. Russell, MD, Alan K. Burnett, MDFRCP, Sylvie Freeman, PhDFRCPath

Blood (2015) 126 (23): 320.

https://doi.org/10.1182/blood.V126.23.320.320

Published: 2015

Journal Articles

Risk-Group Stratified and Minimal Residual Disease (MRD)-Guided Treatment with Extended ATRA and Reduced-Anthracycline Chemotherapy in Childhood Acute Promyelocytic Leukemia (APL): Results from ICC APL Study 01 (NCT01226303; EudraCT 2008-002311-40)

Anna Maria Testi, MD, Andrea Pession, MD, David Grimwade, PhD FRCPath, Daniela Diverio, PhD, Christine Ragu, PhD, Sarah Elitzur, MD, Alcira Fynn, MD, Henrik Hasle, MD PhD, Jutte Van der Werff ten Bosch, MD PhD, Owen Smith, MD, Brenda Gibson, MD, Franco Locatelli, MD PhD, Gertjan J.L. Kaspers, MD PhD

Blood (2015) 126 (23): 563.

https://doi.org/10.1182/blood.V126.23.563.563

Published: 2015

Journal Articles

Aberrant Expression of the MLL5 , BAALC , ID1 , and WT1 Genes Is Associated with Higher Induction Mortality and Poorer Overall Survival in Acute Promyelocytic Leukemia Patients Treated with ATRA and Anthracycline-Based Chemotherapy: An International Consortium On Acute Promyelocytic Leukemia Study

Blood (2012) 120 (21): 1407.

https://doi.org/10.1182/blood.V120.21.1407.1407

Published: 2012

Journal Articles

Comparison Between RT-PCR and RQ-PCR for Minimal Residual Disease Detection in Acute Promyelocytic Leukemia: The International Consortium on Acute Promyelocytic Leukemia (IC-APL) Experience,

Ana Paula Alencar de Lima Lange, Ana Sílvia Gouvea Lima, Rafael Henriques Jacomo, Raul AM Melo, Rosane Bittencourt, MD, Ricardo Pasquini, MD, Katia B. Pagnano, MD, Evandro Fagundes, Maria de Lourdes L. F. Chauffaille, MD, PhD, Carlos S Chiattone, MD, PhD, Robert E. Gallagher, MD, Bob Lowenberg, MD, PhD, Raul Ribeiro, MD, Francesco Lo-Coco, MD, David Grimwade, PhD, Miguel A. Sanz, MD, PhD, Eduardo M. Rego, M.D., Ph.D

Blood (2011) 118 (21): 3552.

https://doi.org/10.1182/blood.V118.21.3552.3552

Published: 2011

Journal Articles

Quantitation of Leukemic Stem Cell Populations Predicts Clinical Outcome in Acute Myeloid Leukaemia

Charles F. Craddock, MD PhD, Nicolas Goardon, PhD, Lynn Quek, MD, Sylvie Freeman, MD, PhD, Shamyla Siddique, Manoj Raghavan, Anna Schuh, PhD, David Grimwade, PhD, Robert K Hills, MA, MSc, DPhil, Cassandra Brookes, PhD, Michael Griffiths, PhD, James D. Cavenagh, MD, Ravindra Majeti, MD, PhD, Irving L. Weissman, MD, Alan K Burnett, MD, Paresh Vyas

Blood (2011) 118 (21): 638.

https://doi.org/10.1182/blood.V118.21.638.638

Published: 2011

Journal Articles

Treatment of Molecular and Clinical Relapse of Acute Promyelocytic Leukemia (APL) with Arsenic Trioxide: Results of the European Registry of Relapsed APL

Eva Lengfelder, MD, PhD, Francesco Lo-Coco, MD, Pau Montesinos, David Grimwade, PhD, Lionel Ades, Bhuvan Kishore, Maria Pagoni, Safaa M. Ramadan, Massimo Breccia, MD, Alexandra Holowiecka, Anne Pradel, Maria Cristina Sauerland, Pierre Fenaux, MD, PhD, Miguel Angel Sanz

Blood (2010) 116 (21): 15.

https://doi.org/10.1182/blood.V116.21.15.15

Published: 2010

Journal Articles

Development of Standardized Approaches to Reporting of Minimal Residual Disease Data Using a Reporting Software Package Designed within the European LeukemiaNet (ELN).

Charlotte G Nyvold, M.Sci., PhD, Mette Oestergaard, M.Sci., PhD, Morten T Andersen, M.Sci., Jelena V Jovanovic, Veli Kairisto, M.D., PhD, Jan K Larsen, MM.Sci., Yvonne G Morgan, Dr., Ugur Ozbek, M.D., PhD, Prof., Niels Pallisgaard, M.Sci., Heike Pfeifer, M.D., David Grimwade, PhD, FRCPath, Peter Hokland, M.D., D., Med., Sci.

Blood (2009) 114 (22): 1619.

https://doi.org/10.1182/blood.V114.22.1619.1619

Published: 2009

Journal Articles

Deregulation of RARγ and RARγ-Specific miRNAs in AML.

Angela N. Barrett, PhD, Rajeev Gupta, MD, Annegret Glasow, PhD, David Grimwade, PhD, Marieke von Lindern, PhD, Samuel Waxman, MD, Ken Mills, PhD, FRCPath, Alan Burnett, PhD, Tariq Enver, PhD, Arthur Zelent, PhD

Blood (2007) 110 (11): 3182.

https://doi.org/10.1182/blood.V110.11.3182.3182

Published: 2007

NARROW

Therapy-Related Myeloid Neoplasms with Balanced Chromosome Rearrangements Frequently Arise from Pre-Existing Clonal Haematopoiesis

Pre-Transplant NPM1 Mutant Transcript Level Is Highly Predictive of Outcome after Allograft and Thresholds Are Dependent on FLT3 ITD Status

Long Term Follow up from the NCRI AML17 Trial of Attenuated Arsenic Trioxide and ATRA Therapy for Newly Diagnosed and Relapsed Acute Promyelocytic Leukaemia

Pml Nuclear Body Disruption Cooperates in APL Pathogenesis, Impacting DNA Damage Repair Pathways

Prognostic Significance and Risk Stratification in Acute Myeloid Leukaemia Patients in the Absence of Successful Cytogenetic Analysis

Significance of Blast CD33 Expression for Effect of Gemtuzumab Ozogamicin at Different Doses in Adult Acute Myeloid Leukemia: Results from the UK NCRI AML16/17 Trials

Risk-Group Stratified and Minimal Residual Disease (MRD)-Guided Treatment with Extended ATRA and Reduced-Anthracycline Chemotherapy in Childhood Acute Promyelocytic Leukemia (APL): Results from ICC APL Study 01 (NCT01226303; EudraCT 2008-002311-40)

Aberrant Expression of the MLL5 , BAALC , ID1 , and WT1 Genes Is Associated with Higher Induction Mortality and Poorer Overall Survival in Acute Promyelocytic Leukemia Patients Treated with ATRA and Anthracycline-Based Chemotherapy: An International Consortium On Acute Promyelocytic Leukemia Study

Comparison Between RT-PCR and RQ-PCR for Minimal Residual Disease Detection in Acute Promyelocytic Leukemia: The International Consortium on Acute Promyelocytic Leukemia (IC-APL) Experience,

Quantitation of Leukemic Stem Cell Populations Predicts Clinical Outcome in Acute Myeloid Leukaemia

Treatment of Molecular and Clinical Relapse of Acute Promyelocytic Leukemia (APL) with Arsenic Trioxide: Results of the European Registry of Relapsed APL

Development of Standardized Approaches to Reporting of Minimal Residual Disease Data Using a Reporting Software Package Designed within the European LeukemiaNet (ELN).

Deregulation of RARγ and RARγ-Specific miRNAs in AML.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only